News
14d
Independent en Español on MSNLas mejores películas de la primera mitad de 2025A menudo, las mejores películas parecen predestinadas a la segunda mitad del año a medida que el Complejo Industrial de los Oscar se pone en marcha. Sin embargo, la primera ...
Moderna announced that its seasonal flu vaccine mRNA-1010 demonstrated 26.6% relative vaccine efficacy compared with standard approved flu vaccines in a phase 3 efficacy trial in adults aged 50 ...
Moderna plans to present these data at an upcoming medical conference and submit for peer-reviewed publication. The Company will engage with regulators on filing submissions for mRNA-1010.
Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza.
Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered positive results in a Phase 3 clinical trial, showing greater efficacy ...
MSD and Moderna start a third phase 3 trial of their V940 cancer vaccine, their second in early-stage lung cancer.
No, side effects from all COVID-19 vaccines are mild and nothing to worry about. But let's look at the specifics and how to cope with them.
CAMBRIDGE, MA / ACCESS Newswire / June 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive results from a Phase 3 efficacy study (P304) evaluating the relative vaccine efficacy (rVE ...
View the profiles of professionals named "Ana Rodríguez Casas" on LinkedIn. There are 6 professionals named "Ana Rodríguez Casas", who use LinkedIn to exchange information, ideas, and opportunities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results